- Cytolon and T-Cell Europe agree on cooperation
- Cytolon initiates global development of DIT - Distributed-Inventory-TechnologyTM
- Cytolon joins Personalized Medicine Coalition
- Cytolon successful with second financing round
- Cytolon gains Patent for CordMatch® in Australia
- Cytolon and DKMS Cord Blood Bank announce collaboration for CordMatch’s Beta-Testing Phase
- Timm Jessen Joins Cytolon’s Supervisory Board
- Cytolon Partners with iSoft for New Life Science Research Tool
- Michaela Servas joins Cytolon´s Supervisory Board
- Cytolon Co-Founder Prof. Dr. Joachim Dudenhausen receives Order of Merit
- CordMatch® goes live
- Cytolon Partners with CSC to Develop CordMatch®
- Cytolon Closes Its First Round of Financing
- Wolfgang Jünger Joins Cytolon's Supervisory Board
- Katherina Reiche, MdB, Steps Down From Cytolon's Supervisory Board to Become a Member of the Federal Government of Germany
- Cytolon Receives the "MOST PROMISING COMPANY LAUNCHED IN 2009 AWARD"
- Cytolon Announces Cooperative Agreement with ARCWAY
- Start-up Financing Begins
- The Launching of Cytolon AG
Cytolon joins Personalized Medicine Coalition
Cytolon AG has joined the Personalized Medicine Coalition, PMC. The education and advocacy organization PMC is representing scientists, patients, providers and payers to promote the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system.
Berlin, 16 June 2011. Cytolon AG has joined the Personalized Medicine Coalition, PMC. The education and advocacy organization PMC is representing scientists, patients, providers and payers to promote the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system.
Thomas Klein, Cytolon’s Founder and Chief Executive Officer, said “we are proud to be a member of the PMC now. Focusing exclusively on personalized medicine, the Coalition is a powerful voice in the debate about how to transform health care. Based on the diversity of its membership and the expertise of its staff, PMC advocates for public policies that will increase investment in and faciliate the adoption of personalized medicine in the near future“.
Edward Abrahams, President of the Personalized Medicine Coalition, added, “We applaud Cytolon and Thomas Klein for their leadership and commitment to personalized medicine. Innovative companies like Cytolon will help us advance personalized medicine in Germany and Europe. PMC is pleased to count on Cytolon as a strong partner to transform the way health care is developed and delivered.”
About Cytolon
Cytolon AG is a technology oriented service provider positioning itself as the first company worldwide to offer intelligent internet platforms that will become necessary for the field of personalized medicine. Cytolon’s first product is an internet based matching platform, CordMatch®. CordMatch® offers efficient cost saving solutions to transplant centers, donor registries, cord blood banks, and pharmaceutical companies which make it possible to provide individually matched stem cell preparations for a high number of cases worldwide. Thomas Klein founded Cytolon AG in 2008. In 2009 Cytolon was awarded the “most promising company launched-Award by Deutsche Bank, Hasso Plattner Ventures. Cytolon is a member of the Association of Research-Based Pharmaceutical Companies (VfA) and the Federal Association for Information Technology, Telecommunications and New Media (BITKOM). Further information can be found at www.cytolon.com.
About the Personalized Medicine Coalition
The Personalized Medicine Coalition, representing scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system. Further information can be found at www.PersonalizedMedicineCoalition.org.
Contact Cytolon AG
Hanna Dudenhausen - Public Relations/ Investor Relations
Cytolon AG
Am Karlsbad 15
10785 Berlin
mobile +49 (0) 151 291 091 26
phone: +49 (0) 30 26 39 288 0
fax: +49 (0) 30 26 39 288 20
hanna.dudenhausen@cytolon.com
Contact PMC
Gwen Gordon
Personalized Medicine Coalition
1225 New York Avenue, NW, Suite 450
Washington, DC 20005
phone: (202) 589-1770
ggordon@PersonalizedMedicineCoalition.org